WARNING: Research shows AndroGel (AbbVie, Inc., Abbott Laboratories, Inc.) is overprescribed and can lead to “serious medical problems, including life threatening cardiac events, strokes, and thrombolytic events.”

AndroGel is a topically-applied gel containing testosterone at concentrations of either 1% or 1.62% used by patients suffering from hypogonadism, or “low-testosterone”.  While this condition does persist in American society today, “Low-T” isn’t nearly as prevalent as the aforementioned companies have led many to believe through what has become an award-winning marketing campaign.

As of February 7th 2014, the United States District Court for the Northern Division of Illinois (Eastern Division) began handling a lawsuit against the manufacturers of AndroGel, in which it is alleged that these companies “participated in, authorized, and directed the production and promotion of [AndroGel] when they knew, or with the exercise of reasonable care should have known, of the hazards and dangerous propensities of [AndroGel] and thereby actively participated in the tortious conduct which resulted in the injuries suffered by [our client].”

It is also noted that the client mentioned above could not have come to know the dangers posed by AndroGel sooner due to the fact that AbbVie and Abbott Laboratories “misrepresented and continue to misrepresent to the public and to the medical profession that the drug AndroGel is safe and free from serious side effects,” stating that these companies “have fraudulently concealed facts and information that could have led [our client] to discover a potential cause of [the side effects experienced].”

This is one of three similar such lawsuits filed that day, all raising the same concerns regarding AndroGel safety and marketing.  To elucidate those concerns, this lawsuit cites several scientific studies.  First, the team cites a 2010 New England Journal of Medicine Study titled “Adverse Events Associated with Testosterone Administration” that was stopped because too many men experienced negative side effects.  Next, the team cites a 2013 Journal of the American Medical Association study titled “Association of Testosterone Therapy with Mortality, Myocardial Infarction, and Stroke in Men with Low Testosterone Levels,” “which indicated that testosterone therapy raised the risk of death, heart attack and stroke by about 30%.”

Another study released January 29th of this year was cited, titled “Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men” determining testosterone therapy doubled the risk for heart attack in men over 65 and younger than 65 who had a history of heart disease.

Though AndroGel commercials describe some of the possible negative side effects of the product, particularly those that can follow by secondary contact (handling the clothes of a person who had applied AndroGel), the risk for heart attack and stroke is absent from their warnings.

As more information becomes available regarding AndroGel lawsuits and the danger of AndroGel, we will be sure to pass the knowledge on to you.  If you or a loved one used AndroGel, you too may be eligible for significant financial compensation as this AndroGel lawsuit proceeds.  For more information, or a free, no-obligation case consultation, contact our team of AndroGel lawyers at the information provided below.  We have the compassion, experience, and resources to win the justice you deserve.  Call today and see how we can help.

(855) 452 – 5529